In line with the focus of the present review, there is substantial evidence for a protective role of Nrf2 in cardiovascular diseases, including atherosclerosis, ischemia–reperfusion (IR) injury, cardiac hypertrophy, heart failure and diabetes (reviewed in [16]), although some harmful effects have also been reported [17,18,19]. This evidence concerns the gene NFE2L2 and cardiac hypertrophy.